Skip to main content

Articles

Page 9 of 61

  1. Pericoronary adipose tissue (PCAT) density is a biomarker of vessel inflammation, which is supposed to be increased in patients with type 2 diabetes mellitus (T2DM). However, whether the coronary inflammation ...

    Authors: Meng-Meng Yu, Xin Zhao, Yin-Yin Chen, Xin-Wei Tao, Jun-Bo Ge, Hang Jin and Meng-Su Zeng
    Citation: Cardiovascular Diabetology 2023 22:121
    Content type: Research Published on:

  2. Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus (DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the clinical impact of DCB-based revascul...

    Authors: Ae-Young Her, Eun-Seok Shin, Sunwon Kim, Bitna Kim, Tae-Hyun Kim, Chang-Bae Sohn, Byung Joo Choi, Yongwhi Park, Jung Rae Cho and Young-Hoon Jeong
    Citation: Cardiovascular Diabetology 2023 22:120
    Content type: Research Published on:

  3. We assessed the impact of 24 months of treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on endothelial function in patients with type 2 diabetes as a sub-analysis of the PROTEC...

    Authors: Shinji Kishimoto, Yukihito Higashi, Takumi Imai, Kazuo Eguchi, Kazuo Fukumoto, Hirofumi Tomiyama, Koji Maemura, Atsushi Tanaka and Koichi Node
    Citation: Cardiovascular Diabetology 2023 22:119
    Content type: Research Published on:

  4. The triglyceride–glucose (TyG) index has been shown to be a new alternative measure for insulin resistance. However, no study has attempted to investigate the association of the TyG index with incident atrial ...

    Authors: Xiao Liu, Ayiguli Abudukeremu, Yuan Jiang, Zhengyu Cao, Maoxiong Wu, Jianyong Ma, Runlu Sun, Wanbing He, Zhiteng Chen, Yangxin Chen, Peng Yu, Wengen Zhu, Yuling Zhang and Jingfeng Wang
    Citation: Cardiovascular Diabetology 2023 22:118
    Content type: Research Published on:

  7. Few studies have assessed the correlation between coexisting mental disorders in participants with diabetes mellitus (DM) and the risk of heart failure (HF). Herein, we conducted a cohort study to determine th...

    Authors: Tae Kyung Yoo, Kyung-Do Han, Eun-Jung Rhee and Won-Young Lee
    Citation: Cardiovascular Diabetology 2023 22:115
    Content type: Research Published on:

  8. Metabolic abnormalities such as dyslipidemia, glucose and high blood pressure are common in diabetic patients. Visit-to-visit variabilities in these measures have been reported as potential residual cardiovasc...

    Authors: Subin Lim, Se Hwa Chung, Ju Hyeon Kim, Yong Hyun Kim, Eung Ju Kim and Hyung Joon Joo
    Citation: Cardiovascular Diabetology 2023 22:114
    Content type: Research Published on:

  9. Coronary microvascular dysfunction (CMD) is a strong determinant of prognosis in patients with chronic coronary syndrome (CCS). The triglyceride-glucose index (TyG index), an alternative method to evaluate ins...

    Authors: Wen Zhang, Lu Liu, Huiying Chen, Siqi Li, Minying Wan, Abdul-Quddus Mohammed, Bin Xu, Guoqing Yin, Xian Lv, Tingting Shi, Jassur Galip, Ayman A. Mohammed, Redhwan M. Mareai, Yawei Xu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:113
    Content type: Research Published on:

  10. Atherosclerosis is a common co-morbidity of type 2 diabetes mellitus. Monocyte recruitment by an activated endothelium and the pro-inflammatory activity of the resulting macrophages are critical components of ...

    Authors: Heng Yu, Hunter F. Douglas, Donald Wathieu, Ryan A. Braun, Christine Edomwande, Daniel J. Lightell Jr., Thaidan Pham, Natasha C. Klingenberg, Shelia Pugh Bishop, Damir B. Khismatullin and T. Cooper Woods
    Citation: Cardiovascular Diabetology 2023 22:112
    Content type: Research Published on:

  11. The triglyceride and glucose (TyG) index has been linked to various cardiovascular diseases. However, it's still unclear whether the TyG index is associated with arterial stiffness and coronary artery calcific...

    Authors: Fuwei Liu, Qin Ling, Shaofeng Xie, Yi Xu, Menglu Liu, Qingwen Hu, Jianyong Ma, Zhiwei Yan, Yan Gao, Yujie Zhao, Wengen Zhu, Peng Yu, Jun Luo and Xiao Liu
    Citation: Cardiovascular Diabetology 2023 22:111
    Content type: Methodology Published on:

  12. This study aimed to explore the association between the triglyceride glucose index (TyG) and the risk of in-hospital and one-year mortality in patients with chronic kidney disease (CKD) and cardiovascular dise...

    Authors: Zixiang Ye, Shuoyan An, Yanxiang Gao, Enmin Xie, Xuecheng Zhao, Ziyu Guo, Yike Li, Nan Shen and Jingang Zheng
    Citation: Cardiovascular Diabetology 2023 22:110
    Content type: Research Published on:

  13. This study compared the risks of cardiovascular morbidity and mortality between patients with type 2 diabetes (T2D) with and without microvascular diseases, and between matched patients with microvascular dise...

    Authors: Fu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, Chih-Cheng Hsu and Chii-Min Hwu
    Citation: Cardiovascular Diabetology 2023 22:109
    Content type: Research Published on:

  14. The FIDELIO-DKD and FIGARO-DKD randomized clinical trials (RCTs) showed finerenone, a novel non-steroidal mineralocorticoid receptor antagonist (MRA), reduced the risk of renal and cardiovascular events in pat...

    Authors: Peter Bramlage, Stefanie Lanzinger, Steffen Mühldorfer, Karsten Milek, Anton Gillessen, Roman Veith, Tobias Ohde, Thomas Danne, Reinhard W. Holl and Jochen Seufert
    Citation: Cardiovascular Diabetology 2023 22:108
    Content type: Research Published on:

  15. Endothelial injury caused by Type 2 diabetes mellitus (T2DM) is considered as a mainstay in the pathophysiology of diabetic vascular complications (DVCs). However, the molecular mechanism of T2DM-induced endot...

    Authors: Shilong You, Jiaqi Xu, Zeyu Yin, Boquan Wu, Pengbo Wang, Mingjun Hao, Cheng Cheng, Mengke Liu, Yuanhui Zhao, Pengyu Jia, Hongkun Jiang, Da Li, Liu Cao, Xingang Zhang, Ying Zhang, Yingxian Sun…
    Citation: Cardiovascular Diabetology 2023 22:107
    Content type: Research Published on:

  16. Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications i...

    Authors: Joonsang Yoo, Jimin Jeon, Minyoul Baik and Jinkwon Kim
    Citation: Cardiovascular Diabetology 2023 22:106
    Content type: Research Published on:

  17. We investigated, using population-based data, whether worse autonomic function, estimated from lower 24-hour heart rate variability (HRV), was associated with beta cell function, asse...

    Authors: Elisabetta Rinaldi, Frank CT van der Heide, Enzo Bonora, Maddalena Trombetta, Chiara Zusi, Abraham A Kroon, Miranda T Schram, Carla JH van der Kallen, Anke Wesselius, Riccardo Bonadonna, Andrea Mari, Casper G Schalkwijk, Marleen MJ van Greevenbroek and Coen DA Stehouwer
    Citation: Cardiovascular Diabetology 2023 22:105
    Content type: Research Published on:

  18. Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and that their circulating concentrations are independe...

    Authors: Damien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, Isabelle Simoneau, Laurent Demizieux, Patricia Passilly-Degrace, Benjamin Bouillet, Jean-Michel Petit, Alexia Rouland, Amandine Bataille, Laurence Duvillard and Bruno Vergès
    Citation: Cardiovascular Diabetology 2023 22:104
    Content type: Research Published on:

  19. Elevated serum uric acid (SUA) is regarded as a risk factor for the development of cardiovascular diseases. Triglyceride-glucose (TyG) index, a novel surrogate for insulin resistance (IR), has been proven to b...

    Authors: Zhenguo Wu, Cheng Cheng, Xiangfei Sun, Juan Wang, Dachuan Guo, Sha Chen, Yerui Zhang, Xiaoyu Liu, Li Liu, Cheng Zhang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2023 22:103
    Content type: Research Published on:

  20. Similarly to cortisol-secreting adrenal tumors, also non-functioning adrenal tumors (NFAT) may be associated with an increased cardiovascular risk. We assessed in NFAT patients: (i) the association between hyp...

    Authors: Vittoria Favero, Carmen Aresta, Chiara Parazzoli, Elisa Cairoli, Cristina Eller-Vainicher, Serena Palmieri, Antonio Stefano Salcuni, Maura Arosio, Luca Persani, Alfredo Scillitani, Valentina Morelli and Iacopo Chiodini
    Citation: Cardiovascular Diabetology 2023 22:102
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:127

  21. Sodium-glucose co-transporter-2 inhibitors are used in the treatment of diabetes but are also emerging as cardioprotective agents in heart diseases even in the absence of type 2 diabetes. In this paper, upon p...

    Authors: Julia Hoehlschen, Dominik Hofreither, Tamara Tomin and Ruth Birner-Gruenberger
    Citation: Cardiovascular Diabetology 2023 22:101
    Content type: Review Published on:

  22. Obesity is an independent risk factor for cardiovascular disease (CVD) in patients with type 2 diabetes (T2D). However, it is not known to what extent weight fluctuations might be associated with adverse outco...

    Authors: Giulia Ferrannini, Carol Pollock, Andrea Natali, Yshai Yavin, Kenneth W. Mahaffey and Ele Ferrannini
    Citation: Cardiovascular Diabetology 2023 22:100
    Content type: Research Published on:

  23. Abdominal ectopic fat deposition and excess visceral fat depots in obesity may be related to cardiovascular disease (CVD) as both are involved in the metabolic syndrome (MetS). The awareness of the link betwee...

    Authors: Yali Qu, Jing Liu, Jing Li, Sumin Shen, Xiaoyi Chen, Hehan Tang, Yuan Yuan, Chunchao Xia, Liping Deng, Guoyong Chen, Tianying Zheng, Jie Chen, Lisha Nie, Fang Yuan, Nanwei Tong, Liqing Peng…
    Citation: Cardiovascular Diabetology 2023 22:99
    Content type: Research Published on:

  24. Since the triglyceride glucose (TyG) index can reflect insulin resistance, it has been proven to be an efficient predictor of glycolipid-metabolism-related diseases. Therefore, this study aimed to investigate ...

    Authors: Qing Yang, Huichao Xu, Hongli Zhang, Yanying Li, Shuxiong Chen, Dongye He, Guangzhi Yang, Bo Ban, Mei Zhang and Fupeng Liu
    Citation: Cardiovascular Diabetology 2023 22:98
    Content type: Research Published on:

  25. Type 2 diabetes mellitus (T2DM) is a frequently observed complication in patients with heart failure with preserved ejection fraction (HFpEF). Although a characteristic finding in such patients is a decrease i...

    Authors: Yousuke Sugita, Katsuhiko Ito, Yui Yoshioka and Satoshi Sakai
    Citation: Cardiovascular Diabetology 2023 22:97
    Content type: Research Published on:

  26. Randomized controlled trials confirm that risks of residual cholesterol and residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid-lowering therapy. This study aims to inv...

    Authors: Ling Yang, Qing Yue, Fang Fang, Yinggen Zhang, Peipei Liu, Zihao Zhang, Guodong Wang, Shuohua Chen, Shouling Wu and Xiuhong Yang
    Citation: Cardiovascular Diabetology 2023 22:96
    Content type: Research Published on:

  27. Authors: Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki and Nobuya Inagaki
    Citation: Cardiovascular Diabetology 2023 22:95
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2023 22:62

  28. Women have a high risk of frailty independently of age and menopause state. Diabetes and hypertension increase the risk of frailty and cognitive impairment. Metformin has been employed in post-menopausal women...

    Authors: Pasquale Mone, Giuseppe Martinelli, Angela Lucariello, Anna Luisa Leo, Anna Marro, Stefano De Gennaro, Stefania Marzocco, Divina Moriello, Salvatore Frullone, Luigi Cobellis and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2023 22:94
    Content type: Research Published on:

  29. To investigate the difference of right ventricular (RV) structural and functional alteration in patients with diabetes mellitus (DM) with preserved left ventricular ejection fraction (LVEF), and the ventricula...

    Authors: Rui Shi, Zhi-Gang Yang, Ying-Kun Guo, Wen-Lei Qian, Yue Gao, Xue-Ming Li, Li Jiang, Hua-Yan Xu and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:93
    Content type: Research Published on:

  30. Acute kidney injury (AKI) can be caused by multiple factors/events, including acute coronary syndrome (ACS). Ceramides are involved in atherosclerosis progression, cardiovascular events, and renal damage. Almo...

    Authors: Lianjing Liang, Dongze Li, Rui Zeng, Haihong Zhang, Lin Lv, Wei Wei and Zhi Wan
    Citation: Cardiovascular Diabetology 2023 22:92
    Content type: Research Published on:

  31. Diabetes mellitus (DM) and atherosclerosis are multifactorial conditions and share a common inflammatory basis. Three-vessel disease (TVD) represents a major challenge for coronary intervention. Nonetheless, t...

    Authors: Lei Guo, Haichen Lv, Junjie Wang, Bo Zhang, Yifan Zhu, Xiaoyan Zhang, Hao Zhu, Xuchen Zhou and Yunlong Xia
    Citation: Cardiovascular Diabetology 2023 22:91
    Content type: Research Published on:

  32. The triglyceride-glucose (TyG) index, a simple measure of insulin resistance, is associated with intracranial atherosclerosis (ICAS) and stroke. In hypertensive populations, this association may be pronounced....

    Authors: Yongle Wang, Tingting Liu, Yanan Li, Kaili Zhang, Haimei Fan, Jing Ren, Juan Li, Yali Li, Xinyi Li, Xuemei Wu, Junhui Wang, Lixi Xue, Xiaolei Gao, Yuping Yan, Gaimei Li, Qingping Liu…
    Citation: Cardiovascular Diabetology 2023 22:90
    Content type: Research Published on:

  33. L-Arginine (L-Arg), is a semi-essential amino acid involved in the formation of nitric oxide. The functional relevance of L-Arg in diabetes mellitus has been evaluated both in animal models and in human subjec...

    Authors: Imma Forzano, Roberta Avvisato, Fahimeh Varzideh, Stanislovas S. Jankauskas, Angelo Cioppa, Pasquale Mone, Luigi Salemme, Urna Kansakar, Tullio Tesorio, Valentina Trimarco and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2023 22:89
    Content type: Review Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:117

  34. An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arr...

    Authors: Petra Hrabalova, Romana Bohuslavova, Katerina Matejkova, Frantisek Papousek, David Sedmera, Pavel Abaffy, Frantisek Kolar and Gabriela Pavlinkova
    Citation: Cardiovascular Diabetology 2023 22:88
    Content type: Research Published on:

  35. The triglyceride glucose (TyG) index is a well-established biomarker for insulin resistance (IR) that shows correlation with poor outcomes in patients with coronary artery disease. We aimed to integrate the Ty...

    Authors: Zongwei Ye, Yanan Xu, Long Tang, Min Wu, Bing Wu, Tongjian Zhu and Jun Wang
    Citation: Cardiovascular Diabetology 2023 22:87
    Content type: Research Published on:

  37. In recent years, several studies have demonstrated that stress hyperglycemia is significantly associated with poor prognosis in patients diagnosed with acute coronary syndrome (ACS). In the present study, we a...

    Authors: Qu-Cheng Wei, Yu-wen Chen, Qi-Yue Gao, Kai-Da Ren, Ya-Bin Liu, Fan He, Jia-Tong Shi and Jun Jiang
    Citation: Cardiovascular Diabetology 2023 22:85
    Content type: Research Published on:

  38. Obesity is linked to cardiometabolic diseases, however non-obese individuals are also at risk for type 2 diabetes (T2D) and cardiovascular disease (CVD). White adipose tissue (WAT) is known to play a role in b...

    Authors: Narmadha Subramanian, Kaisa Hofwimmer, Beatriz Tavira, Lucas Massier, Daniel P Andersson, Peter Arner and Jurga Laurencikiene
    Citation: Cardiovascular Diabetology 2023 22:84
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:229

  40. A new definition of metabolically healthy obesity (MHO) has recently been proposed to stratify the heterogeneous mortality risk of obesity. Metabolomic profiling provides clues to metabolic alterations beyond ...

    Authors: Dongmei Wei, Vannina González-Marrachelli, Jesus D Melgarejo, Chia-Te Liao, Angie Hu, Stefan Janssens, Peter Verhamme, Lucas Van Aelst, Thomas Vanassche, Josep Redon, Maria Tellez-Plaza, Juan C Martin-Escudero, Daniel Monleon and Zhen-Yu Zhang
    Citation: Cardiovascular Diabetology 2023 22:82
    Content type: Research Published on:

  41. Coronary artery calcium (CAC) improves cardiovascular event prediction. Visceral adipose tissue (VAT) is a cardiometabolic risk factor that may directly or through its related comorbidities determine the obesi...

    Authors: Neftali Eduardo Antonio-Villa, Juan Gabriel Juárez-Rojas, Rosalinda Posadas-Sánchez, Juan Reyes-Barrera and Aida Medina-Urrutia
    Citation: Cardiovascular Diabetology 2023 22:81
    Content type: Research Published on:

  42. Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to reduction of major adverse cardiovascular events (MA...

    Authors: Celestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, Cosimo Sacra, Gerardo Carpinella, Ciro Mauro, Fabio Minicucci, Paolo Calabrò, Michele D’ Amico, Fabrizio D’ Ascenzo, Ovidio De Filippo, Mario Iannaccone, Carmine Pizzi, Giuseppe Paolisso and Raffaele Marfella
    Citation: Cardiovascular Diabetology 2023 22:80
    Content type: Research Published on:

  43. Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes ...

    Authors: Pierre Gourdy, Patrice Darmon, François Dievart, Jean-Michel Halimi and Bruno Guerci
    Citation: Cardiovascular Diabetology 2023 22:79
    Content type: Review Published on:

  44. Diffuse myocardial fibrosis and microvascular dysfunction are suggested to underlie cardiac dysfunction in patients with type 2 diabetes, but studies investigating their relative impact are lacking. We aimed t...

    Authors: Annemie S. Bojer, Martin H. Sørensen, Stine H. Madsen, David A. Broadbent, Sven Plein, Peter Gæde and Per L. Madsen
    Citation: Cardiovascular Diabetology 2023 22:78
    Content type: Research Published on:

  45. Diabetes mellitus (DM) type 2 is an independent risk factor for atrial fibrillation (AF). Surgical ablation or "maze procedure" is an option for patients with AF undergoing concomitant or isolated cardiac surg...

    Authors: Alexander Kogan, Avishay Grupper, Avi Sabbag, Eilon Ram, Tamer Jamal, Eyal Nof, Enrique Z. Fisman, Shany Levin, Roy Beinart, Jonathan Frogel, Ehud Raanani and Leonid Sternik
    Citation: Cardiovascular Diabetology 2023 22:77
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:116

  46. Previous studies have shown that the stress hyperglycemia ratio (SHR), a parameter of relative stress-induced hyperglycemia, is an excellent predictive factor for all-cause mortality and major adverse cardiova...

    Authors: Zehuo Lin, Xueqing Liang, Yeshen Zhang, Yining Dai, Lin Zeng, Weikun Chen, Siyu Kong, Pengcheng He, Chongyang Duan and Yuanhui Liu
    Citation: Cardiovascular Diabetology 2023 22:76
    Content type: Research Published on:

  47. The triglyceride glucose-body mass index (TyG-BMI index) has been considered a reliable surrogate measure of insulin resistance; however, its ability to predict the incidence of cardiovascular disease in indiv...

    Authors: Yang Cheng, Zhen Fang, Xinxin Zhang, Yuchen Wen, Jiaqi Lu, Shenghu He and Bing Xu
    Citation: Cardiovascular Diabetology 2023 22:75
    Content type: Research Published on:

  48. Chronic kidney disease (CKD) is a common comorbidity in people with diabetes mellitus, and a key risk factor for further life-threatening conditions such as cardiovascular disease. The early prediction of prog...

    Authors: Michael Kammer, Andreas Heinzel, Karin Hu, Heike Meiselbach, Mariella Gregorich, Martin Busch, Kevin L. Duffin, Maria F. Gomez, Kai-Uwe Eckardt and Rainer Oberbauer
    Citation: Cardiovascular Diabetology 2023 22:74
    Content type: Research Published on:

  49. Estimating cardiovascular (CV) event accrual is important for outcome trial planning. Limited data exist describing event accrual patterns in patients with type 2 diabetes (T2D). We compared apparent CV event ...

    Authors: M. Angelyn Bethel, Harald Sourij, Susanna R. Stevens, Karen Hannan, Yuliya Lokhnygina, Amanda I. Adler, Eric D. Peterson, Rury R. Holman and Renato D. Lopes
    Citation: Cardiovascular Diabetology 2023 22:72
    Content type: Research Published on:

  50. High-density lipoprotein cholesterol’s (HDL-C) long-held status as a cardiovascular disease (CVD) preventative has been called into question. Most of the evidence, however, focused on either the risk of death ...

    Authors: Hye Jun Kim, Seogsong Jeong, Yun Hwan Oh, Sun Jae Park, Yoosun Cho and Sang Min Park
    Citation: Cardiovascular Diabetology 2023 22:71
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840